Toolkit/SIBR-Cas

SIBR-Cas

Multi-Component Switch·Research·Since 2021

Also known as: Self-splicing Intron-Based Riboswitch-Cas

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

SIBR-Cas, termed Self-splicing Intron-Based Riboswitch-Cas, is a multi-component bacterial CRISPR genome engineering system that provides inducible control over CRISPR-Cas counterselection. It is reported to delay counterselection to permit editing events and has been applied to gene knockout in bacteria with poor homologous recombination systems.

Usefulness & Problems

Why this is useful

SIBR-Cas is useful for bacterial genome engineering because it provides inducible and reportedly tight regulation of CRISPR-Cas counterselection. The cited study positions it as a simple and widely applicable approach for non-model bacteria, including hosts with poor homologous recombination systems.

Source:

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas

Problem solved

This system addresses the problem that immediate CRISPR-Cas counterselection can prevent recovery of edited cells before recombination occurs. It is specifically presented as enabling gene knockout in bacteria with poor homologous recombination capacity without exogenous recombinases.

Source:

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Target processes

editingrecombinationselection

Implementation Constraints

The available evidence indicates that SIBR-Cas is a multi-component system built around a self-splicing intron-based riboswitch for inducible control of CRISPR-Cas counterselection. It was used for bacterial gene knockout without exogenous recombinases, but the supplied evidence does not specify the Cas protein, intron architecture, inducer, construct design, or delivery method.

The supplied evidence does not provide quantitative editing efficiencies, leakiness measurements, inducer identity, or direct comparisons against specific alternative systems. Validation is described from a single 2021 source, so independent replication and breadth across diverse bacterial taxa are not established here.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Observations

successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3
successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3
successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3
successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3
successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3
successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3
successBacteriaapplication demo

Inferred from claim c4 during normalization. Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems. Derived from claim c4. Quoted text: Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

number of bacteria3

Supporting Sources

Ranked Claims

Claim 1application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 2application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 3application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 4application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 5application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 6application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 7application resultsupports2021Source 1needs review

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.
number of bacteria 3
Claim 8comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 9comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 10comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 11comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 12comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 13comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 14comparative advantagesupports2021Source 1needs review

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.
Claim 15mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 16mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 17mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 18mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 19mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 20mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 21mechanismsupports2021Source 1needs review

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.
Claim 22mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 23mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 24mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 25mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 26mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 27mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 28mechanismsupports2021Source 1needs review

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection
Claim 29proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 30proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 31proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 32proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 33proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 34proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 35proposed applicationsupports2021Source 1needs review

SIBR is proposed as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria.

we propose that SIBR can have a wider application as a universal gene expression and gene regulation control mechanism for any gene or RNA of interest in bacteria
Claim 36tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas
Claim 37tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas
Claim 38tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas
Claim 39tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas
Claim 40tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas
Claim 41tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas
Claim 42tool descriptionsupports2021Source 1needs review

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas

Approval Evidence

1 source5 linked approval claimsfirst-pass slug sibr-cas
we termed SIBR-Cas (Self-splicing Intron-Based Riboswitch-Cas)

Source:

application resultsupports

Without exogenous recombinases, SIBR-Cas was successfully applied to knock out several genes in three bacteria with poor homologous recombination systems.

Without the use of exogenous recombinases, SIBR-Cas was successfully applied to knock-out several genes in three bacteria with poor homologous recombination systems.

Source:

comparative advantagesupports

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated, and widely applicable for most non-model bacteria.

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.

Source:

mechanismsupports

Delaying CRISPR-Cas counterselection grants more time for the editing event to occur.

This control delays CRISPR-Cas counterselection, granting more time for the editing event (e.g., by homologous recombination) to occur.

Source:

mechanismsupports

SIBR-Cas provides universal and inducible control over CRISPR-Cas counterselection.

allows for universal and inducible control over CRISPR-Cas counterselection

Source:

tool descriptionsupports

SIBR-Cas is a simple and universal genome engineering tool for bacteria.

developing a simple and universal genome engineering tool for bacteria which we termed SIBR-Cas

Source:

Comparisons

Source-backed strengths

The reported strengths are simplicity, tight regulation, and broad applicability across most non-model bacteria. In the cited work, SIBR-Cas was successfully used without exogenous recombinases to knock out several genes in three bacterial species with poor homologous recombination systems.

Source:

Compared to other genome engineering tools, SIBR-Cas is simple, tightly regulated and widely applicable for most (non-model) bacteria.

Ranked Citations

  1. 1.

    Extracted from this source document.